Faculty

The Center Faculty come from all four UCSF Schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

Judith Hellman, MD

Professor
Anesthesia

My research program is focused on basic and translational research on sepsis and other forms of inflammation-driven acute organ failure ("Inflammatory Critical Illness"). Sepsis and multiple organ failure are leading causes of death in the Intensive Care Unit. These processes result from a complex inflammatory response that is initiated through the innate immune system by interactions between host cells and microbes or endogenous host factors that are released during injury or cell death. The family of Toll-like receptors (TLRs) recognize different microbial components and endogenous host factors, and are critical in initiating inflammatory responses to infection. The Hellman Group studies TLR-dependent pathways expressed by macrophages as well as non-conventional inflammatory cells, including endothelial cells, in Inflammatory Critical Illness, focusing on their roles in coagulopathy, vascular permeability, neutrophil trafficking to organs, and organ injury and failure.

Carolyn Hendrickson, MD, MPH

Assistant Professor
Medicine

Effect of smoke on Acute Respiratory Distress Syndrome

Robert A. Hiatt, MD, PhD

Professor
Epidemiology & Biostatistics

Cancer epidemiology and studies of cancer etiology, early development, the environment and social determinants.

Salomeh Keyhani, MD

Professor
Medicine

Lisa Kroon, PharmD

Professor & Chair
Clinical Pharmacy

Tobacco cessation education and training of health professionals.

Susan Lee, MD

Asst Adjunct
Anesthesia

Feasibility and acceptability of e-cigarettes versus nicotine replacement therapy for smoking cessation in the perioperative period.

James Lightwood, PhD

Associate Professor
Clinical Pharmacy

Estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws.

Pamela Ling, MD

Professor
Medicine

Tobacco industry marketing strategies targeting young adults, women, and other high risk population, and new smokeless and novel tobacco product marketing strategies with focus on how to use tobacco industry marketing strategies to improve tobacco control programs.

Ruth Malone, RN, PhD, FAAN

Professor
Social Behavioral Sciences

Tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use.

Jyothi Marbin, MD

Associate Professor
Pediatrics

Impact of tobacco on low income, urban children and reducing the burden of secondhand smoke on children with focus on the impact of electronic health record changes on clinical uptake of tobacco cessation interventions, as well as the use of online trainings to train physicians on smoking cessation.

Pages